Sobha Joseph
Papers
1
Total Citations
12
H-Index
1
About
Dr. Sobha Joseph is a leading ophthalmology researcher whose work centers on innovative treatments for retinal diseases, particularly neovascular age-related macular degeneration (nAMD). Her most significant contribution is the pivotal STAR trial, a double-masked, sham-controlled study evaluating stereotactic radiotherapy as a therapy for nAMD. This landmark research demonstrated that ionizing radiation can mitigate key pathogenic processes underlying the disease, offering a potential alternative to the standard anti-VEGF injections that require frequent intravitreal administration. With 12 citations in 2024 alone, the STAR trial has already garnered substantial attention for its rigorous methodology and promising results. Dr. Joseph’s work addresses a critical unmet need: reducing treatment burden while maintaining efficacy for patients at risk of blindness. Her research bridges radiation oncology and ophthalmology, showcasing a multidisciplinary approach to chronic retinal conditions. By exploring non-invasive or less invasive interventions, she is shaping future therapeutic paradigms. For students and researchers, Dr. Joseph exemplifies how translational clinical trials can directly impact patient care, and her contributions underscore the importance of innovative trial design in advancing ophthalmic medicine.
Research Focus
Key Achievements
Top Papers
- 1